Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220021008 220009534 1.69 60 null null 2017-12-08 FLA 02 N 220036228 VENETOCLAX
220021009 220009542 null null Curative (C) 2019-02-03 2019-05-17 Alemtuzumab + Cyclophos TBI Allo null null 220036248 FLUDARABINE
220021010 220021928 1.75 86.2 Curative (C) 2017-07-09 2017-09-26 Cetuximab 7 day (Cycle 1) N null 220036280 IPM
220021011 220009558 1.81 108 Curative (C) 2017-08-11 2017-09-10 Methotrexate High Dose (3g/m2) N null 220036334 EC
220021012 220009560 null 9.7 Curative (C) 2016-11-13 2016-12-11 Cytarabine+Methotrexate Intrathecal null N 220036338 CARBOPLATIN + CETUXIMAB + FU
220021013 220009578 1.65 null Palliative (P) 2018-07-15 2018-08-13 BUSULFAN + FLUDARABINE null N 220036432 CETUXIMAB + CISPLATIN + FU
220021014 220018225 null 45 Curative (C) 2017-03-14 2017-03-14 Alemtuzumab + Cyclophos TBI Allo null N 220036524 ALEMTUZUMAB + CYCLOPHOSPHAMIDE
220021016 220009608 1.83 86 Curative (C) 2018-05-18 2018-07-08 Trabectedin 01 N 220036563 SPANISH MAINTENANCE
220021017 220009620 1.75 86 Curative (C) 2014-08-22 2014-09-10 MidAC N Y 220036606 DACTINOMYCIN
220021018 220009626 0 62 Curative (C) 2016-03-24 2016-03-24 ROMAZA TRIAL N null 220036614 DABRAFENIB
220021019 220009631 1.75 82 Palliative (P) 2018-01-22 2018-02-07 PEMBROLIZUMAB N N 220036629 FIGARO TRIAL
220021020 220009641 1.65 null null 2014-12-11 2014-12-11 Etoposide oral N N 220036641 BUSULFAN + FLUDARABINE
220021021 220009657 1.55 87.2 null 2017-12-16 2018-04-26 Cladribine (subcut) 5 days 02 N 220036675 CODOX M
220021022 220009660 1.24 null Palliative (P) 2018-06-21 2018-06-22 Arsenic trioxide 02 N 220036683 CYTARABINE IT + METHOTREXATE
220021023 220009681 null 103 Curative (C) 2013-09-29 2013-10-13 Cytarabine+Methotrexate Intrathecal null null 220000653 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN
220021024 220009684 1.3 75 Palliative (P) 2016-05-30 2016-05-31 DHAP 99 null 220002814 CLOFARABINE + DAUNORUBICIN
220021025 220009690 1.84 81.7 Disease modification (D) 2017-03-26 2017-05-05 FIGARO TRIAL N N 220004682 CYTARABINE + MITOXANTRONE
220021026 220009701 1.92 105.8 Curative (C) null 2018-12-13 ALL UKALL60+ TRIAL 2 N 220014128 CYTARABINE + MITOXANTRONE
220021027 220009714 1.56 70 Disease modification (D) 2018-05-25 2018-05-25 Carboplatin AUC 6 - 10 02 N 220018242 MITOXANTRONE + TRETINOIN
220021028 220009730 null null Palliative (P) 2015-08-13 2015-09-10 Alemtuzumab + Cyclophos TBI Allo N N 220021070 EOX
220021029 220009735 1.68 45.4 Disease modification (D) 2017-03-07 2017-03-12 Cetuximab+Cisplatin+FU (> Cycle 2) N N 220021758 MITOXANTRONE + TRETINOIN
220021030 220009743 1.67 80 Palliative (P) 2015-09-21 2015-10-19 ALL UKALL2011 Maintenance A1 01 null 220022881 IPO
220021031 220020013 1.85 null Palliative (P) 2015-09-29 2017-07-12 DHAP - R null N 220028838 EOX
220021032 220015147 1.55 94 Palliative (P) 2019-09-05 2019-09-17 Arsenic Triox + Tretinoin Ind W1-4 02 N 220029686 FIGARO TRIAL
220021033 220009783 1.8 102.2 null 2017-11-29 2017-12-05 INTERFERON N N 220032124 MITOXANTRONE + TRETINOIN
220021034 220009785 1.75 45.4 null 2018-05-14 2018-11-01 Irinotecan 14day 02 N 220032395 CAPECITABINE
220021035 220018264 null 86.5 Palliative (P) 2018-09-24 2018-09-24 PEMBROLIZUMAB N null 220034024 CETUXIMAB + CISPLATIN + FU
220021036 220009795 1.69 41.2 Curative (C) null 2014-03-28 Cisplatin + Etoposide (3 day) N N 220034048 BUSULFAN + CYCLOPHOSPHAMIDE
220021037 220009805 1.67 66.2 Disease modification (D) 2015-04-06 2015-04-13 Etoposide oral 2 N 220034508 DABRAFENIB + TRAMETINIB
220021038 220009813 null -1 Curative (C) 2017-08-15 2017-08-21 BUSULFAN + FLUDARABINE null N 220035216 METHOTREXATE + PEGASPARGASE
220021039 220009823 1.79 81.1 Curative (C) 2015-03-26 2015-04-04 MA (Cytarabine 3g/m2) N N 220020987 TRASTUZUMAB
220021040 220021040 1.72 89.5 Palliative (P) 2019-06-21 2019-07-23 Atezolizumab N N 220026545 UKALL60+
220021041 220004061 0 124.75 Disease modification (D) null 2016-11-10 IMATINIB N N 220000242 IMATINIB
220021043 220004070 null 0 Disease modification (D) 2017-05-07 2017-05-07 IMATINIB N N 220000450 IMATINIB
220021044 220012157 1.8 0 Disease modification (D) 2018-06-01 2018-11-30 IMATINIB N N 220000723 IMATINIB
220021045 220004085 1.75 0 Disease modification (D) 2017-07-01 2017-08-25 IMATINIB 02 N 220000807 IMATINIB
220021046 220004087 0 0 Palliative (P) 2017-09-09 2017-09-09 Imatinib 400mg N N 220001016 IMATINIB
220021047 220004091 null null Curative (C) 2010-04-11 2013-11-15 IMATINIB null null 220001105 IMATINIB
220021048 220016589 null 47 Disease modification (D) 2015-12-22 2017-05-07 Imatinib 400mg N N 220001130 IMATINIB
220021049 220004100 1.68 null Curative (C) 2017-05-22 2017-07-04 Imatinib 400mg null N 220001182 IMATINIB
220021057 220004219 1.88 115 Curative (C) 2014-02-14 2014-03-14 IMATINIB null N 220003878 IMATINIB
220021058 220004236 1.65 49 Disease modification (D) 2017-05-30 2017-07-20 Imatinib 400mg 02 N 220004202 IMATINIB
220021059 220004244 1.77 null null 2014-01-01 2014-09-28 IMATINIB N N 220004771 IMATINIB
220021061 220012236 null null Curative (C) 2016-04-26 2018-10-06 Imatinib 400mg null null 220004877 IMATINIB
220021062 220004289 null null Palliative (P) 2013-02-08 2014-06-15 IMATINIB null null 220005650 IMATINIB
220021064 220004330 0 0 Curative (C) null 2014-07-04 IMATINIB N N 220007037 IMATINIB
220021065 220004333 0 0 Palliative (P) null 2016-06-13 IMATINIB 2 N 220007069 IMATINIB
220021067 220004349 0 null null 2014-01-25 2014-01-25 Imatinib 400mg N N 220007267 IMATINIB
220021068 220004353 1.77 70 Palliative (P) null 2017-02-17 Imatinib 400mg N N 220007300 IMATINIB
220021069 220004364 null 0 Palliative (P) null 2014-02-19 IMATINIB N N 220007575 IMATINIB